Comparison of two supplement oxygen methods during gastroscopy with intravenous propofol anesthesia in obese patients: study protocol for a randomized controlled trial.

Trials

Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-An Road, Xi-Cheng District, Beijing, 100050, People's Republic of China.

Published: November 2018

Background: Hypoxemia is a major complication in obese patients undergoing gastrointestinal endoscopy under intravenous anesthesia or sedation due to altered airway anatomy. We design this randomized controlled trial (RCT) to compare efficacy and safety of the Wei nasal jet tube (WNJT) and nasal prongs for supplement oxygen during gastroscopy with intravenous propofol anesthesia in obese patients.

Methods: The study will be a single-center, prospective RCT. A total of 308 obese patients will be recruited and randomly assigned to receive either the WNJT (group A) or nasal prongs (group B). During gastroscopy with intravenous propofol anesthesia, 5 L/min of oxygen will be delivered through the jet port of the WNJT in the group A and via the nasal prongs in the group B. The primary outcome is the incidence of hypoxemia and severe hypoxemia. The secondary outcomes are adverse events during the gastroscopy, postoperative complications, and satisfaction of the anesthetist, physician, and patient.

Discussion: This RCT aims to clarify whether the WNJT can result in reduced incidences of hypoxemia and complications and provide improved satisfaction to the anesthetist, physician, and patient. Thus, it can be determined if the WNJT is a useful tool for supplement oxygen in obese patients undergoing gastroscopy with intravenous propofol anesthesia. The results will provide the evidence for anesthesiologists to make a decision regarding the choice of supplementary oxygen methods in this condition.

Trial Registration: Chinese Clinical Trial, ChiCTR-IOR-17013089 . Registered on 23 October 2017.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211481PMC
http://dx.doi.org/10.1186/s13063-018-2994-8DOI Listing

Publication Analysis

Top Keywords

gastroscopy intravenous
16
intravenous propofol
16
propofol anesthesia
16
obese patients
16
supplement oxygen
12
nasal prongs
12
oxygen methods
8
anesthesia obese
8
randomized controlled
8
controlled trial
8

Similar Publications

Risk factors for gastric mucosa lesion in critically ill patients undergoing endoscopy for percutaneous gastrostomy: a case-control study.

BMC Gastroenterol

December 2024

Department of Gastroenterology and Hepatology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyków 14, Katowice, 40-752, Poland.

Background: Pharmacologic prophylaxis for gastric ulcer is commonly prescribed in patients hospitalized in the intensive care unit (ICU). The aim of the study was to assess the current prevalence and risk factors for gastric mucosa lesion in ICU patients receiving standard pharmacologic prophylaxis undergoing endoscopy for percutaneous gastrostomy implantation.

Methods: Patients hospitalized in the mixed medical-surgical ICU undergoing percutaneous endoscopic gastrostomy (PEG) were analyzed.

View Article and Find Full Text PDF

Remimazolam is an ultra-short-acting intravenous benzodiazepine derivative approved for sedation during gastroscopy and colonoscopy. The present study aimed to compare the safety and efficacy of remimazolam and propofol for general anesthesia with tracheal intubation by meta-analysis. A comprehensive search was conducted in databases, including PubMed, Embase, Cochrane Library and Web of Science, to identify relevant randomized controlled trials (RCTs).

View Article and Find Full Text PDF
Article Synopsis
  • Ciprofol has been shown to cause less injection pain compared to propofol in procedures like gastroscopy, but its effects during painless hysteroscopy were not fully understood until this study.
  • A randomized controlled trial with 217 patients found that the injection pain rate was significantly lower in the ciprofol group (18.35%) compared to the propofol group (40.74%), while both groups had a 100% sedation success rate.
  • Ciprofol also resulted in fewer adverse events, higher patient satisfaction scores, and more stable blood pressure measurements than propofol, indicating it may be a better option for anesthesia in painless procedures.
View Article and Find Full Text PDF
Article Synopsis
  • Intravenous ciprofol is a fast-acting sedative, and the study tested how intravenous lidocaine affects the dose needed for ciprofol during painless gastroscopy in 70 patients.
  • Patients were split into two groups: one received ciprofol with lidocaine, while the other received ciprofol with saline, measuring outcomes like the effective dose of ciprofol and recovery times.
  • Results showed that lidocaine significantly lowered the required ciprofol dose and improved recovery times and postoperative comfort, highlighting its beneficial role in sedation during procedures.
View Article and Find Full Text PDF

Background: Vancomycin-induced bleeding has been reported, attributed to the mechanism of immune thrombocytopenia. A rare case of vancomycin-induced gastrointestinal hemorrhage in a young patient with no underlying disease, receiving intravenous vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) infection, is presented. This occurrence occurred without thrombocytopenia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!